CBE has been widely used to inhibit the lysosomal glucosylceramide-degrading enzyme (glucocerebrosidase, GBA) in live cells and has even been used as a method of mimicking certain genetic metabolic disorders such as Gaucher disease [11, 12]. Here, GBA1 is linked to Gaucher disease.